Skip to content
Subscriber Only

MorphoSys Rises on Expanded Novartis Partnership: Munich Mover

MorphoSys AG rose the most in six weeks after saying it will expand an alliance with Novartis AG, using new technology to boost the discovery of medicines with the Swiss drug maker.

The German company’s shares advanced as much as 6.3 percent, the biggest gain since Sept. 24, and were up 4.4 percent at 26.22 euros at 1:25 p.m. in Frankfurt. That extended the stock’s gain this year to 50 percent.